WEEBIT NANO LTD (ASX:WBT) - Weebit - 2024 and beyond, page-1232 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum

Originally posted by Bren19: ↑

Humans are really weird, rogerst posts things like "Mram charging ahead" or ultraram is the future etc, I am not really sure why.

It is a really interesting and strange human behavior - its kind of tribalistic like you see in crypto or sports etc, but at the same time its kind of not that.

Would be really interesting to see a psychologist's take on it, its really fascinating

Ofcause not everyone that posts or thinks negatively on WBT fits this i think it would be good if there were posts from people that genuinely don't think WBT's future is bright and have the technical knowledge to explain why they think these things. As well as the soft skills to actually articulate their arguments.

As a software dev I don't have the technical knowledge to be overly positive or negative about the company/tech over the next decade, i can only understand the problem that WBT is solving and at a pretty fundamental level how the tech solves that problem based on what I read and my own understanding which i fully admit is limited and i think if people are honest there is likely only a very small number of people on here that do understand it past that.

But once again the question for me isn't which emerging NVM will be the ONLY viable option in the future, because the answer to that is there isn't one, there are always going to be considerations which makes one more favorable to another (power consumption vs performance vs cost vs durability vs availability), if ultraram was available and costs the same then in some situations it would be the better choice, however in a power consumption vs performance than my understanding is that reram would be the better choice.

The question is within the next 6-12 months (or sooner) will there be an opportunity from the price it is now to make money.

Roger thinks the SP will go down, and i think he is correct, and I intend to buy as it does, but i think it will eventually within that time period go up and i think it will go up quite a lot more than it will go down...

Roger also thinks there will be a need for CR soon too but there is no logic on this one that i can follow as we have 4 years of funding available according to the latest Activities Report, so a CR within the next 12 months would be very strange indeed.

I am not loyal though i'll buy 4DS or some other stock if i think it will double or triple, I don't go down the pub wearing a WBT t-shirt and lime green face paint.

Expand

"Humans are really weird, rogerst posts things like "Mram charging ahead" or ultraram is the future etc, I am not really sure why.

It is a really interesting and strange human behavior - its kind of tribalistic like you see in crypto or sports etc, but at the same time its kind of not that.

Would be really interesting to see a psychologist's take on it, its really fascinating"

I think it would be interesting to see a psychologist's take on
- why regulars on the wbt thread haven't put roger and a few others on ignore
- why they reply and comment on such irrelevance if they haven't put them on ignore

No.	Vol.	Price($)
2	4262	$2.50

No.

Vol.

Price($)

4262

$2.50

Price($)	Vol.	No.
$2.52	27000	2

Price($)

Vol.

No.

$2.52

27000

No.	Vol.	Price($)
2	4262	2.500
1	3306	2.490
2	5306	2.480
3	24117	2.450
2	1913	2.430

No.

Vol.

Price($)

4262

2.500

3306

2.490

5306

2.480

24117

2.450

1913

2.430

Price($)	Vol.	No.
2.520	27000	2
2.530	2182	1
2.540	4097	2
2.550	38653	5
2.560	1278	2

Price($)

Vol.

No.

2.520

27000

2.530

2182

2.540

4097

2.550

38653

2.560

1278

(20min delay)
Last $2.50		Change 0.080(3.31%)		Mkt cap ! $472.2M

Open	High	Low	Value	Volume
$2.42	$2.54	$2.41	$1.358M	543.7K

Weebit - 2024 and beyond, page-1232

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Patagonia looks to raise $2.15M for South American exploration and development

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Weebit - 2024 and beyond, page-1232

Top Stories

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Patagonia looks to raise $2.15M for South American exploration and development

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News